O	O	O	0	9	Increased	Increase	B-NP	VBN	O	3	NMOD	O
O	O	O	10	17	IkappaB	IkappaB	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	18	28	expression	expression	I-NP	NN	O	9	NMOD	O
O	O	O	29	32	and	and	O	CC	O	9	NMOD	O
O	O	O	33	43	diminished	diminish	B-VP	VBD	O	9	NMOD	O
T2	B-Entity	B-Entity	44	51	nuclear	nuclear	B-NP	JJ	B-protein	9	NMOD	B-protein
T2,T3	I-Entity,B-Entity	I-Entity,B-Entity	52	54	NF	NF	I-NP	NN	I-protein	9	NMOD	I-protein
T2,T3	I-Entity,I-Entity	I-Entity,I-Entity	54	55	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T2,T3	I-Entity,I-Entity	I-Entity,I-Entity	55	61	kappaB	kappaB	I-NP	NN	I-protein	0	ROOT	I-protein
O	O	O	62	64	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	65	70	human	human	B-NP	JJ	B-cell_type	13	NMOD	B-cell_type
O	O	O	71	82	mononuclear	mononuclear	I-NP	JJ	I-cell_type	13	NMOD	I-cell_type
O	O	O	83	88	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	89	98	following	follow	B-PP	VBG	O	9	NMOD	O
O	O	O	99	113	hydrocortisone	hydrocortisone	B-NP	NN	O	16	NMOD	O
O	O	O	114	123	injection	injection	I-NP	NN	O	14	PMOD	O
O	O	O	123	124	.	.	O	.	O	9	P	O

O	O	O	126	128	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	129	133	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	134	142	recently	recently	I-VP	RB	O	2	VMOD	O
O	O	O	143	155	demonstrated	demonstrate	I-VP	VBN	O	2	VC	O
O	O	O	156	160	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	161	175	hydrocortisone	hydrocortisone	B-NP	NN	O	9	NMOD	O
O	O	O	176	179	and	and	O	CC	O	9	NMOD	O
O	O	O	180	185	other	other	B-NP	JJ	O	9	NMOD	O
O	O	O	186	201	glucocorticoids	glucocorticoid	I-NP	NNS	O	10	SUB	O
O	O	O	202	209	inhibit	inhibit	B-VP	VBP	O	5	SBAR	O
O	O	O	210	218	reactive	reactive	B-NP	JJ	O	13	NMOD	O
O	O	O	219	225	oxygen	oxygen	I-NP	NN	O	13	NMOD	O
O	O	O	226	233	species	specie	I-NP	NNS	O	17	NMOD	O
O	O	O	234	235	(	(	O	(	O	16	DEP	O
O	O	O	235	238	ROS	ROS	B-NP	NN	O	16	DEP	O
O	O	O	238	239	)	)	O	)	O	13	NMOD	O
O	O	O	240	250	generation	generation	B-NP	NN	O	10	OBJ	O
O	O	O	251	253	by	by	B-PP	IN	O	17	NMOD	O
O	O	O	254	265	mononuclear	mononuclear	B-NP	JJ	O	25	NMOD	O
O	O	O	266	267	(	(	O	(	O	22	DEP	O
O	O	O	267	270	MNC	MNC	B-NP	NN	B-cell_type	22	DEP	B-cell_type
O	O	O	270	271	)	)	O	)	O	19	NMOD	O
O	O	O	272	275	and	and	O	CC	O	25	NMOD	O
O	O	O	276	293	polymorphonuclear	polymorphonuclear	B-NP	JJ	B-cell_type	25	NMOD	B-cell_type
O	O	O	294	304	leucocytes	leucocyte	I-NP	NNS	I-cell_type	18	PMOD	I-cell_type
O	O	O	305	306	(	(	O	(	O	28	DEP	O
O	O	O	306	310	PMNL	PMNL	B-NP	NN	B-cell_type	28	DEP	B-cell_type
O	O	O	310	311	)	)	O	)	O	25	NMOD	O
O	O	O	311	312	.	.	O	.	O	2	P	O

O	O	O	313	318	Since	Since	B-SBAR	IN	O	23	VMOD	O
T4	B-Entity	B-Entity	319	321	NF	NF	B-NP	NN	B-protein	4	NMOD	B-protein
T4	I-Entity	I-Entity	321	322	-	-	B-NP	HYPH	I-protein	4	P	I-protein
T4	I-Entity	I-Entity	322	328	kappaB	kappaB	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	O	328	329	/	/	I-NP	SYM	O	7	NMOD	O
O	O	O	329	336	IkappaB	IkappaB	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	337	343	system	system	I-NP	NN	O	8	SUB	O
O	O	O	344	353	regulates	regulate	B-VP	VBZ	O	1	SBAR	O
O	O	O	354	357	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	358	371	transcription	transcription	I-NP	NN	O	8	OBJ	O
O	O	O	372	374	of	of	B-PP	IN	O	10	NMOD	O
T5	B-Entity	B-Entity	375	390	proinflammatory	proinflammatory	B-NP	JJ	B-DNA	13	NMOD	B-DNA
T5	I-Entity	I-Entity	391	396	genes	gene	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	O	396	397	,	,	O	,	O	13	P	O
O	O	O	398	407	including	include	B-PP	VBG	O	13	NMOD	O
O	O	O	408	413	those	those	B-NP	DT	O	15	PMOD	O
O	O	O	414	425	responsible	responsible	B-ADJP	JJ	O	16	NMOD	O
O	O	O	426	429	for	for	B-PP	IN	O	17	AMOD	O
O	O	O	430	433	ROS	ROS	B-NP	NN	O	20	NMOD	O
O	O	O	434	444	generation	generation	I-NP	NN	O	18	PMOD	O
O	O	O	444	445	,	,	O	,	O	23	P	O
O	O	O	446	448	we	we	B-NP	PRP	O	23	SUB	O
O	O	O	449	455	tested	test	B-VP	VBD	O	0	ROOT	O
O	O	O	456	459	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	460	470	hypothesis	hypothesis	I-NP	NN	O	23	OBJ	O
O	O	O	471	475	that	that	B-SBAR	IN	O	25	NMOD	O
O	O	O	476	490	hydrocortisone	hydrocortisone	B-NP	NN	O	28	SUB	O
O	O	O	491	494	may	may	B-VP	MD	O	26	SBAR	O
O	O	O	495	504	stimulate	stimulate	I-VP	VB	O	28	VC	O
O	O	O	505	512	IkappaB	IkappaB	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	O	513	523	production	production	I-NP	NN	O	29	OBJ	O
O	O	O	524	528	thus	thus	O	RB	O	33	VMOD	O
O	O	O	529	539	inhibiting	inhibit	B-VP	VBG	O	29	VMOD	O
T6	B-Entity	B-Entity	540	542	NF	NF	B-NP	NN	B-protein	36	NMOD	B-protein
T6	I-Entity	I-Entity	542	543	-	-	I-NP	HYPH	I-protein	36	NMOD	I-protein
T6	I-Entity	I-Entity	543	549	kappaB	kappaB	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	O	550	563	translocation	translocation	I-NP	NN	O	33	OBJ	O
O	O	O	564	568	from	from	B-PP	IN	O	33	VMOD	O
O	O	O	569	572	the	the	B-NP	DT	O	40	NMOD	O
O	O	O	573	580	cytosol	cytosol	I-NP	NN	O	38	PMOD	O
O	O	O	581	585	into	into	B-PP	IN	O	38	PMOD	O
O	O	O	586	589	the	the	B-NP	DT	O	43	NMOD	O
O	O	O	590	597	nucleus	nucleus	I-NP	NN	O	41	PMOD	O
O	O	O	598	600	in	in	B-PP	IN	O	43	NMOD	O
O	O	O	601	604	MNC	MNC	B-NP	NN	B-cell_type	44	PMOD	B-cell_type
O	O	O	604	605	,	,	O	,	O	33	P	O
O	O	O	606	608	in	in	B-ADVP	FW	O	33	VMOD	O
O	O	O	609	613	vivo	vivo	I-ADVP	FW	O	47	AMOD	O
O	O	O	613	614	.	.	O	.	O	23	P	O

O	O	O	615	618	One	One	B-NP	CD	O	3	NMOD	O
O	O	O	619	626	hundred	hundred	I-NP	CD	O	3	NMOD	O
O	O	O	627	636	milligram	milligram	I-NP	NN	O	6	SUB	O
O	O	O	637	639	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	640	654	hydrocortisone	hydrocortisone	B-NP	NN	O	4	PMOD	O
O	O	O	655	658	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	659	667	injected	inject	I-VP	VBN	O	6	VC	O
O	O	O	668	681	intravenously	intravenously	B-ADVP	RB	O	7	VMOD	O
O	O	O	682	686	into	into	B-PP	IN	O	7	VMOD	O
O	O	O	687	688	4	4	B-NP	CD	O	12	NMOD	O
O	O	O	689	695	normal	normal	I-NP	JJ	O	12	NMOD	O
O	O	O	696	704	subjects	subject	I-NP	NNS	O	9	PMOD	O
O	O	O	704	705	.	.	O	.	O	6	P	O

O	O	O	706	711	Blood	Blood	B-NP	NN	O	2	NMOD	O
O	O	O	712	719	samples	sample	I-NP	NNS	O	3	SUB	O
O	O	O	720	724	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	725	733	obtained	obtain	I-VP	VBN	O	3	VC	O
O	O	O	734	739	prior	prior	B-ADVP	RB	O	4	VMOD	O
O	O	O	740	742	to	to	B-PP	TO	O	5	PMOD	O
O	O	O	743	746	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	747	756	injection	injection	I-NP	NN	O	6	PMOD	O
O	O	O	757	760	and	and	B-PP	CC	O	5	PMOD	O
O	O	O	761	763	at	at	B-PP	IN	O	5	PMOD	O
O	O	O	764	765	1	1	B-NP	CD	O	19	NMOD	O
O	O	O	765	766	,	,	I-NP	,	O	19	P	O
O	O	O	767	768	2	2	I-NP	CD	O	19	NMOD	O
O	O	O	768	769	,	,	I-NP	,	O	19	P	O
O	O	O	770	771	4	4	I-NP	CD	O	19	NMOD	O
O	O	O	771	772	,	,	I-NP	,	O	19	P	O
O	O	O	773	774	8	8	I-NP	CD	O	19	NMOD	O
O	O	O	775	778	and	and	I-NP	CC	O	19	NMOD	O
O	O	O	779	781	24	24	I-NP	CD	O	20	NMOD	O
O	O	O	782	784	hr	hr	I-NP	NN	O	10	PMOD	O
O	O	O	785	790	after	after	B-PP	IN	O	20	NMOD	O
O	O	O	791	794	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	795	804	injection	injection	I-NP	NN	O	21	PMOD	O
O	O	O	804	805	.	.	O	.	O	3	P	O

O	O	O	806	813	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD	O
O	O	O	814	822	extracts	extract	I-NP	NNS	O	6	NMOD	O
O	O	O	823	826	and	and	O	CC	O	6	NMOD	O
O	O	O	827	832	total	total	B-NP	JJ	O	6	NMOD	O
O	O	O	833	837	cell	cell	I-NP	NN	O	6	NMOD	O
O	O	O	838	845	lysates	lysate	I-NP	NNS	O	7	SUB	O
O	O	O	846	850	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	851	859	prepared	prepare	I-VP	VBN	O	7	VC	O
O	O	O	860	864	from	from	B-PP	IN	O	8	VMOD	O
O	O	O	865	868	MNC	MNC	B-NP	NN	B-cell_type	9	PMOD	B-cell_type
O	O	O	869	871	by	by	B-PP	IN	O	8	VMOD	O
O	O	O	872	880	standard	standard	B-NP	JJ	O	13	NMOD	O
O	O	O	881	891	techniques	technique	I-NP	NNS	O	11	PMOD	O
O	O	O	891	892	.	.	O	.	O	7	P	O

O	O	O	893	900	IkappaB	IkappaB	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	901	907	levels	level	I-NP	NNS	O	6	SUB	O
O	O	O	908	910	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	911	914	MNC	MNC	B-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	O	915	926	homogenates	homogenate	I-NP	NNS	O	3	PMOD	O
O	O	O	927	936	increased	increase	B-VP	VBD	O	0	ROOT	O
O	O	O	937	939	at	at	B-PP	IN	O	6	VMOD	O
O	O	O	940	941	1	1	B-NP	CD	O	9	NMOD	O
O	O	O	942	944	hr	hr	I-NP	NN	O	7	PMOD	O
O	O	O	944	945	,	,	O	,	O	6	P	O
O	O	O	946	952	peaked	peak	B-VP	VBD	O	6	VMOD	O
O	O	O	953	955	at	at	B-PP	IN	O	11	VMOD	O
O	O	O	956	957	2	2	B-NP	CD	O	16	NMOD	O
O	O	O	957	958	-	-	I-NP	HYPH	O	16	NMOD	O
O	O	O	958	959	4	4	I-NP	CD	O	16	NMOD	O
O	O	O	960	962	hr	hr	I-NP	NN	O	12	PMOD	O
O	O	O	962	963	,	,	O	,	O	6	P	O
O	O	O	964	971	started	start	B-VP	VBD	O	6	VMOD	O
O	O	O	972	974	to	to	I-VP	TO	O	20	VMOD	O
O	O	O	975	983	decrease	decrease	I-VP	VB	O	18	VMOD	O
O	O	O	984	986	at	at	B-PP	IN	O	20	VMOD	O
O	O	O	987	988	8	8	B-NP	CD	O	23	NMOD	O
O	O	O	989	991	hr	hr	I-NP	NN	O	21	PMOD	O
O	O	O	991	992	,	,	O	,	O	6	P	O
O	O	O	993	996	and	and	O	CC	O	6	VMOD	O
O	O	O	997	1005	returned	return	B-VP	VBD	O	6	VMOD	O
O	O	O	1006	1008	to	to	B-PP	TO	O	26	VMOD	O
O	O	O	1009	1017	baseline	baseline	B-NP	NN	O	29	NMOD	O
O	O	O	1018	1024	levels	level	I-NP	NNS	O	27	PMOD	O
O	O	O	1025	1027	at	at	B-PP	IN	O	26	VMOD	O
O	O	O	1028	1030	24	24	B-NP	CD	O	32	NMOD	O
O	O	O	1031	1033	hr	hr	I-NP	NN	O	30	PMOD	O
O	O	O	1033	1034	.	.	O	.	O	6	P	O

T7	B-Entity	B-Entity	1035	1037	NF	NF	B-NP	NN	B-protein	3	NMOD	B-protein
T7	I-Entity	I-Entity	1037	1038	-	-	I-NP	HYPH	I-protein	3	NMOD	I-protein
T7	I-Entity	I-Entity	1038	1044	kappaB	kappaB	I-NP	NN	I-protein	8	SUB	I-protein
O	O	O	1045	1047	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	1048	1051	MNC	MNC	B-NP	NN	B-cell_type	7	NMOD	B-cell_type
O	O	O	1052	1059	nuclear	nuclear	I-NP	JJ	O	7	NMOD	O
O	O	O	1060	1068	extracts	extract	I-NP	NNS	O	4	PMOD	O
O	O	O	1069	1078	decreased	decrease	B-VP	VBD	O	0	ROOT	O
O	O	O	1079	1081	at	at	B-PP	IN	O	8	VMOD	O
O	O	O	1082	1083	1	1	B-NP	CD	O	11	NMOD	O
O	O	O	1084	1086	hr	hr	I-NP	NN	O	9	PMOD	O
O	O	O	1086	1087	,	,	O	,	O	8	P	O
O	O	O	1088	1095	reached	reach	B-VP	VBD	O	8	VMOD	O
O	O	O	1096	1097	a	a	B-NP	DT	O	15	NMOD	O
O	O	O	1098	1103	nadir	nadir	I-NP	NN	O	13	OBJ	O
O	O	O	1104	1106	at	at	B-PP	IN	O	13	VMOD	O
O	O	O	1107	1108	4	4	B-NP	CD	O	18	NMOD	O
O	O	O	1109	1111	hr	hr	I-NP	NN	O	16	PMOD	O
O	O	O	1111	1112	,	,	O	,	O	8	P	O
O	O	O	1113	1122	gradually	gradually	B-ADVP	RB	O	8	VMOD	O
O	O	O	1123	1132	increased	increase	B-VP	VBD	O	8	VMOD	O
O	O	O	1133	1135	at	at	B-PP	IN	O	21	VMOD	O
O	O	O	1136	1137	8	8	B-NP	CD	O	24	NMOD	O
O	O	O	1138	1140	hr	hr	I-NP	NN	O	22	PMOD	O
O	O	O	1141	1144	and	and	O	CC	O	8	VMOD	O
O	O	O	1145	1153	returned	return	B-VP	VBD	O	8	VMOD	O
O	O	O	1154	1158	back	back	B-ADVP	RB	O	26	VMOD	O
O	O	O	1159	1161	to	to	B-PP	TO	O	27	AMOD	O
O	O	O	1162	1170	baseline	baseline	B-NP	NN	O	30	NMOD	O
O	O	O	1171	1177	levels	level	I-NP	NNS	O	28	PMOD	O
O	O	O	1178	1180	at	at	B-PP	IN	O	26	VMOD	O
O	O	O	1181	1183	24	24	B-NP	CD	O	33	NMOD	O
O	O	O	1184	1186	hr	hr	I-NP	NN	O	31	PMOD	O
O	O	O	1186	1187	.	.	O	.	O	8	P	O

O	O	O	1188	1191	The	The	B-NP	DT	O	4	NMOD	O
O	O	O	1192	1197	total	total	I-NP	JJ	O	4	NMOD	O
O	O	O	1198	1205	protein	protein	I-NP	NN	O	4	NMOD	O
O	O	O	1206	1213	content	content	I-NP	NN	O	17	SUB	O
O	O	O	1214	1216	of	of	B-PP	IN	O	4	NMOD	O
T8	B-Entity	B-Entity	1217	1219	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T8	I-Entity	I-Entity	1219	1220	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T8	I-Entity	I-Entity	1220	1226	kappaB	kappaB	B-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	1227	1234	subunit	subunit	I-NP	NN	O	5	PMOD	O
O	O	O	1235	1236	(	(	O	(	O	12	DEP	O
T1	B-Protein	B-Protein	1236	1239	P65	P65	B-NP	NN	B-protein	12	DEP	B-protein
O	O	O	1239	1240	)	)	O	)	O	9	NMOD	O
O	O	O	1241	1243	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	1244	1247	MNC	MNC	B-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	O	1248	1255	lysates	lysate	I-NP	NNS	O	13	PMOD	O
O	O	O	1256	1260	also	also	B-ADVP	RB	O	17	VMOD	O
O	O	O	1261	1267	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	1268	1269	a	a	B-NP	DT	O	19	NMOD	O
O	O	O	1270	1278	decrease	decrease	I-NP	NN	O	17	OBJ	O
O	O	O	1279	1288	following	follow	B-PP	VBG	O	17	VMOD	O
O	O	O	1289	1303	hydrocortisone	hydrocortisone	B-NP	NN	O	22	NMOD	O
O	O	O	1304	1313	injection	injection	I-NP	NN	O	20	PMOD	O
O	O	O	1313	1314	.	.	O	.	O	17	P	O

O	O	O	1315	1319	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	1320	1328	decrease	decrease	I-NP	NN	O	3	SUB	O
O	O	O	1329	1332	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1333	1341	observed	observe	I-VP	VBN	O	3	VC	O
O	O	O	1342	1344	at	at	B-PP	IN	O	4	VMOD	O
O	O	O	1345	1346	2	2	B-NP	CD	O	7	NMOD	O
O	O	O	1347	1349	hr	hr	I-NP	NN	O	5	PMOD	O
O	O	O	1349	1350	,	,	O	,	O	3	P	O
O	O	O	1351	1358	reached	reach	B-VP	VBD	O	3	VMOD	O
O	O	O	1359	1360	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	1361	1366	nadir	nadir	I-NP	NN	O	9	OBJ	O
O	O	O	1367	1369	at	at	B-PP	IN	O	9	VMOD	O
O	O	O	1370	1371	4	4	B-NP	CD	O	14	NMOD	O
O	O	O	1372	1374	hr	hr	I-NP	NN	O	12	PMOD	O
O	O	O	1374	1375	,	,	O	,	O	3	P	O
O	O	O	1376	1379	and	and	O	CC	O	3	VMOD	O
O	O	O	1380	1388	returned	return	B-VP	VBD	O	3	VMOD	O
O	O	O	1389	1391	to	to	B-PP	TO	O	17	VMOD	O
O	O	O	1392	1400	baseline	baseline	B-NP	NN	O	20	NMOD	O
O	O	O	1401	1407	levels	level	I-NP	NNS	O	18	PMOD	O
O	O	O	1408	1410	at	at	B-PP	IN	O	17	VMOD	O
O	O	O	1411	1413	24	24	B-NP	CD	O	23	NMOD	O
O	O	O	1414	1416	hr	hr	I-NP	NN	O	21	PMOD	O
O	O	O	1416	1417	.	.	O	.	O	3	P	O

O	O	O	1418	1421	ROS	ROS	B-NP	NN	O	3	NMOD	O
O	O	O	1422	1432	generation	generation	I-NP	NN	O	3	NMOD	O
O	O	O	1433	1443	inhibition	inhibition	I-NP	NN	O	4	SUB	O
O	O	O	1444	1454	paralleled	parallel	B-VP	VBD	O	0	ROOT	O
T9	B-Entity	B-Entity	1455	1457	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T9	I-Entity	I-Entity	1457	1458	-	-	B-NP	HYPH	I-protein	7	P	I-protein
T9	I-Entity	I-Entity	1458	1464	kappaB	kappaB	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	O	1465	1471	levels	level	I-NP	NNS	O	4	OBJ	O
O	O	O	1472	1474	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	1475	1478	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	1479	1486	nucleus	nucleus	I-NP	NN	O	9	PMOD	O
O	O	O	1486	1487	.	.	O	.	O	4	P	O

O	O	O	1488	1490	It	It	B-NP	PRP	O	2	SUB	O
O	O	O	1491	1494	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1495	1504	inhibited	inhibit	I-VP	VBN	O	2	VC	O
O	O	O	1505	1507	at	at	B-PP	IN	O	3	VMOD	O
O	O	O	1508	1509	1	1	B-NP	CD	O	6	NMOD	O
O	O	O	1510	1512	hr	hr	I-NP	NN	O	4	PMOD	O
O	O	O	1512	1513	,	,	O	,	O	2	P	O
O	O	O	1514	1521	reached	reach	B-VP	VBD	O	2	VMOD	O
O	O	O	1522	1523	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	1524	1529	nadir	nadir	I-NP	NN	O	8	OBJ	O
O	O	O	1530	1532	at	at	B-PP	IN	O	8	VMOD	O
O	O	O	1533	1534	2	2	B-NP	CD	O	15	NMOD	O
O	O	O	1534	1535	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	O	1535	1536	4	4	I-NP	CD	O	15	NMOD	O
O	O	O	1537	1539	hr	hr	I-NP	NN	O	11	PMOD	O
O	O	O	1539	1540	,	,	O	,	O	2	P	O
O	O	O	1541	1548	started	start	B-VP	VBD	O	2	VMOD	O
O	O	O	1549	1551	to	to	I-VP	TO	O	19	VMOD	O
O	O	O	1552	1560	increase	increase	I-VP	VB	O	17	VMOD	O
O	O	O	1561	1563	at	at	B-PP	IN	O	19	VMOD	O
O	O	O	1564	1565	8	8	B-NP	CD	O	22	NMOD	O
O	O	O	1566	1568	hr	hr	I-NP	NN	O	20	PMOD	O
O	O	O	1568	1569	,	,	O	,	O	2	P	O
O	O	O	1570	1573	and	and	O	CC	O	2	VMOD	O
O	O	O	1574	1582	returned	return	B-VP	VBD	O	2	VMOD	O
O	O	O	1583	1585	to	to	B-PP	TO	O	25	VMOD	O
O	O	O	1586	1591	basal	basal	B-NP	JJ	O	28	NMOD	O
O	O	O	1592	1598	levels	level	I-NP	NNS	O	26	PMOD	O
O	O	O	1599	1601	at	at	B-PP	IN	O	25	VMOD	O
O	O	O	1602	1604	24	24	B-NP	CD	O	31	NMOD	O
O	O	O	1605	1607	hr	hr	I-NP	NN	O	29	PMOD	O
O	O	O	1607	1608	.	.	O	.	O	2	P	O

O	O	O	1609	1612	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1613	1617	data	datum	I-NP	NNS	O	3	SUB	O
O	O	O	1618	1629	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	1630	1634	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1635	1649	hydrocortisone	hydrocortisone	B-NP	NN	O	6	SUB	O
O	O	O	1650	1657	induces	induce	B-VP	VBZ	O	4	SBAR	O
O	O	O	1658	1665	IkappaB	IkappaB	B-NP	NN	B-protein	6	OBJ	B-protein
O	O	O	1666	1669	and	and	O	CC	O	6	VMOD	O
O	O	O	1670	1680	suppresses	suppress	B-VP	VBZ	O	6	VMOD	O
T10	B-Entity	B-Entity	1681	1683	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T10	I-Entity	I-Entity	1683	1684	-	-	O	HYPH	I-protein	13	NMOD	I-protein
T10	I-Entity	I-Entity	1684	1690	kappaB	kappaB	B-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1691	1701	expression	expression	I-NP	NN	O	9	OBJ	O
O	O	O	1702	1704	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	1705	1708	MNC	MNC	B-NP	NN	B-cell_type	14	PMOD	B-cell_type
O	O	O	1709	1711	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	1712	1720	parallel	parallel	B-NP	NN	O	16	PMOD	O
O	O	O	1720	1721	.	.	O	.	O	3	P	O

O	O	O	1722	1729	IkappaB	IkappaB	B-NP	NN	B-protein	3	SUB	B-protein
O	O	O	1730	1737	further	further	B-ADVP	RBR	O	3	VMOD	O
O	O	O	1738	1745	reduces	reduce	B-VP	VBZ	O	0	ROOT	O
O	O	O	1746	1749	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1750	1763	translocation	translocation	I-NP	NN	O	3	OBJ	O
O	O	O	1764	1766	of	of	B-PP	IN	O	5	NMOD	O
T11	B-Entity	B-Entity	1767	1769	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T11	I-Entity	I-Entity	1769	1770	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T11	I-Entity	I-Entity	1770	1776	kappaB	kappaB	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	1777	1781	into	into	B-PP	IN	O	5	NMOD	O
O	O	O	1782	1785	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1786	1793	nucleus	nucleus	I-NP	NN	O	10	PMOD	O
O	O	O	1794	1798	thus	thus	B-ADVP	RB	O	14	VMOD	O
O	O	O	1799	1809	preventing	prevent	B-VP	VBG	O	3	VMOD	O
O	O	O	1810	1813	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1814	1824	expression	expression	I-NP	NN	O	14	OBJ	O
O	O	O	1825	1827	of	of	B-PP	IN	O	16	NMOD	O
T12	B-Entity	B-Entity	1828	1843	proinflammatory	proinflammatory	B-NP	JJ	B-DNA	19	NMOD	B-DNA
T12	I-Entity	I-Entity	1844	1849	genes	gene	I-NP	NNS	I-DNA	17	PMOD	I-DNA
O	O	O	1849	1850	.	.	O	.	O	3	P	O
